Home
Rosalind

Rosalind Market Share Analysis for July 2026

ROSALIND® Analysis Platform is Now Available to all nCounter Users | OnRamp BioInformatics

Science and Education > Biology

Domainrosalind.bio

Year Founded2013

Employees51 - 200

Annual Revenue--

Rosalind

Rosalind (including company regionals)

rosalind.bio

See more website traffic and engagement information

Total visits to Rosalind's top domains

Understand Rosalind market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

rosalind.bio13.4K

See more with Sales Intelligence

Avg. visit duration in Rosalind's top domains

Analyze Rosalind engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

rosalind.bio00:00:22

See more with Sales Intelligence

Avg. pageviews on Rosalind's top domains

See how Rosalind keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

rosalind.bio2.34

See more with Sales Intelligence

Rosalind top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Rosalind

These are the website technologies, by industry, used by Rosalind top domains

Advertising (10)

Google Adsense

Payment & Currencies (7)

PayPal

Conversion & Analytics (5)

Google Analytics

Marketing (5)

Google Marketing Platform

More Technologies

10

See all

News & Signals from Rosalind

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsGENEWIZ Group partners with ROSALIND, Inc..To help researchers gain these insights, the Next Generation Sequencing (NGS) team at GENEWIZ has partnered with ROSALIND to offer a complete sequencing to data analysis approach for analyzing scRNA-Seq data.

NewsROSALIND, Inc. launches The ROSALIND Tracker.SAN DIEGO, CA – June 29, 2022 – ROSALIND®, a software leader in extracting meaningful insights from diverse pools of life science data, today announced the launch of a web-based platform, The ROSALIND Tracker for monitoring the emergence of SARS-CoV-2 variants, including Delta, and the latest variant of concern, Omicron.

NewsRebusbio partnered with ROSALIND, Inc. on Jun 8th '22.Rebus Biosystems Inc, ("Rebus Bio", "Rebus"), an Illumina Ventures-backed life science technology company creating revolutionary tools to advance spatial omics research, announced today it is partnering with Rosalind, Inc. to co-develop new spatial omics software.